| Authors: |
Israel E; Pulmonary and Critical Care Medicine, Allergy and Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Castro M; Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Llanos JP; Global Medical Affairs, Amgen, Thousand Oaks, CA, USA., Molfino NA; Global Development, Amgen, Thousand Oaks, CA, USA., Martin NL; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.; Cytel Inc., Waltham, MA, USA., Ponnarambil SS; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Martin N; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; University of Leicester, Leicester, UK. |
